Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-07-11
2006-07-11
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07074774
ABSTRACT:
The present invention has disclosed a use of N-acetyl-D-glucosamine in the manufacture of a medicament for resisting cardiac and cerebral ischemia and oxygen-deficiency. N-acetyl-D-glucosamine can obviously prolong the survival time of the experimental animal under the condition of cerebral ischemia and oxygen-deficiency at normal pressure, can decrease cerebral edema degree and other symptoms of the nerve behavior caused by cerebral ischemia and re-infusion.
REFERENCES:
patent: 4696919 (1987-09-01), Hinohara et al.
patent: 1156026 (1997-08-01), None
patent: 1156027 (1997-08-01), None
patent: 1156028 (1997-08-01), None
patent: 93/14765 (1993-08-01), None
patent: 93/18775 (1993-09-01), None
Collard, C.D, et al. “Complement Activation after Oxidative Stress Role of the Lectin Comlement Pathway” American Journal of Pathology, vol. 156 No. 5 (2000) pp. 1549-1556.
Liu Junkang
Xu Qiwang
Yuan Zetao
Bio-Wave Institute of Suzhou Hi-Teach New District Corporation L
Jiang Shaojia Anna
Ladas and Parry LLP
McIntosh III Traviss C.
Third Military Medical University Chinese People's Liberation Ar
LandOfFree
Use of N-acetyl-D-glucosamine in the manufacture of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of N-acetyl-D-glucosamine in the manufacture of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of N-acetyl-D-glucosamine in the manufacture of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3546288